Normal Hemostasis Values in Premature Infants

University Hospital, Strasbourg, France1,000 enrolled

Overview

This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Premature Infant, Hemostasis

Eligibility

Sex: ALLMin age: 0 MonthsMax age: 18 Months

Medical Language ↔ Plain English

Inclusion Criteria: * Patients aged 18 months or younger for whom a sample was sent to the Hematology Laboratory at Strasbourg University Hospital for measurement of a hemostasis parameter Exclusion Criteria: * Patients with incomplete data * Patients with a congenital hemostasis disorder (hemophilia A or B, von Willebrand disease), a coagulopathy, or hepatocellular insufficiency

Locations (1)

Laboratoire d'Hématologie - CHU de Strasbourg - France

Strasbourg, France

RECRUITING

Outcomes

Primary Outcomes

Normal hemostasis values in premature infants

Normal hemostasis values in premature infants will be determined according to the gestational age at birth

Time frame: Up to 6 years

Central Contacts

Agathe HERB, PharmD

CONTACT

33 3 88 12 75 53 agathe.herb@chru-strasbourg.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.